ONCOPRO HEREDITARY CANCER RISK PANEL: 200 GENES (N237)
₹30,200
About This Test
This test is useful for assessing the risk of hereditary cancer. The test covers 200 genes targetting hereditary cancers. The genes selected are based on the NCCN guidelines and peer reviewed literature. The cancers covered are Breast, Ovarian, Uterine, Stomach, Endocrine Pancreas, Esophagus, Colorectal, Endometrium, Ovarian, Bone, Thyroid, Kidneys, Urinary tract, Lung, Prostate, Central nervous system, Head & Neck, Liver, Cervix, Exocrine Pancreas, Small Intestine, Blood, Soft tissue, Skin, Peripheral nervous system & Endocrine glands.
At a Glance
Home Collection
Available
Report TAT
37 Days
Category
OUTSOURCE
Preparation / Prerequisite
10 mL (8 mL min.) Whole blood in 1 Lavender Top (EDTA) tube. Ship immediately at 18–22°C. DO NOT REFRIGERATE OR FREEZE. Duly filled Oncopro Hereditary Cancer Risk Clinical Information Form (Form 27) is mandatory.
Frequently Asked Questions
1. What Is outsourced test ?
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
2. Any Preparation for the test ?
No special preparation required
3. Why this test is important ?
The OncoPro Hereditary Cancer Risk Panel (200 Genes) is important because it helps identify inherited genetic mutations that increase cancer risk, enabling early detection, prevention, and personalized management.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
